The suppression of colon cancer cell growth in nude mice by targeting β-catenin/TCF pathway

Ka Yin Kwong, Yiyu Zou, Chi Ping Day, Mien Chie Hung

Research output: Contribution to journalArticle

38 Scopus citations

Abstract

The adenomatous polyposis coli (APC) or β-catenin genes are frequently mutated in colorectal cancers, leading to activation of downstream genes with β-catenin/T-cell factor (Tcf)-responsive promoters. We have developed a gene therapy approach selectively targeting colorectal cancer cells in which β-catenin/Tcf4 pathway is activated by using a recombinant adenovirus AdTOP-CMV-TK, which carries a herpes simplex virus thymidine kinase gene (HSV TK) under the control of a β-catenin/Tcf-response promoter linking to a minimum CMV promoter. AdTOP-CMV-TK and ganciclovir (GCV) treatment significantly suppressed the growth of human DLD-1 colon cancer cells in nude mice. Furthermore, no significant tumor suppression effect was observed in human hepatoma cell line SK-HEP-1, in which the β-catenin/Tcf pathway is not activated, as a control experiment. In summary, we demonstrated the selective targeting of colorectal cancers with activated β-catenin by AdTOP-CMV-TK and GCV treatment in animal models, as well as its therapeutic potential for colon cancer metastasized to liver.

Original languageEnglish (US)
Pages (from-to)8340-8346
Number of pages7
JournalOncogene
Volume21
Issue number54
DOIs
Publication statusPublished - Nov 28 2002
Externally publishedYes

    Fingerprint

Keywords

  • APC
  • Adeno-virus
  • Colon cancer
  • Tcf
  • Thymidine kinase
  • β-catenin

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this